Gainers
- Novo Integrated Sciences (NASDAQ:NVOS) stock rose 15.4% to $0.3 during Friday's after-market session. Today's trading volume for this security ended up closing at 6.8 million shares, which is 15.5 percent of its average volume over the last 100 days. The company's market cap stands at $47.2 million.
- NexImmune (NASDAQ:NEXI) shares moved upwards by 6.22% to $0.22. This security traded at a volume of 72.5K shares come close, making up 50.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $5.7 million.
- iBio (AMEX:IBIO) shares moved upwards by 6.09% to $0.33. The company's market cap stands at $7.4 million.
- Beyond Air (NASDAQ:XAIR) stock increased by 5.26% to $2.8. The market value of their outstanding shares is at $88.7 million.
- VolitionRX (AMEX:VNRX) stock rose 5.25% to $0.73. The company's market cap stands at $57.0 million.
- Genprex (NASDAQ:GNPX) shares increased by 5.13% to $0.41. The market value of their outstanding shares is at $24.2 million.
Losers
- MSP Recovery (NASDAQ:LIFW) stock decreased by 9.4% to $0.21 during Friday's after-market session. This security traded at a volume of 15.6 million shares come close, making up 56.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $71.4 million.
- Exicure (NASDAQ:XCUR) stock fell 7.66% to $0.72. The market value of their outstanding shares is at $6.2 million.
- ContraFect (NASDAQ:CFRX) stock fell 7.53% to $0.55. The company's market cap stands at $5.8 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares declined by 7.28% to $0.12. At the close, China SXT Pharmaceuticals's trading volume reached 78.5K shares. This is 2.0% of its average volume over the last 100 days. The company's market cap stands at $1.7 million.
- Synaptogenix (NASDAQ:SNPX) shares fell 6.35% to $0.34. This security traded at a volume of 353.0K shares come close, making up 36.1% of its average volume over the last 100 days. The company's market cap stands at $3.4 million.
- TransCode Therapeutics (NASDAQ:RNAZ) shares decreased by 5.6% to $0.64. TransCode Therapeutics's trading volume hit 83.1K shares by close, accounting for 14.2% of its average volume over the last 100 days. The company's market cap stands at $1.2 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.